{
    "id": "5e51dab06d0a27794100003d",
    "question": "Is deletion at 6q24.2-26 associated with shorter survival for ovarian cancer patients?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, I will consider the available scientific literature and research findings related to the association between deletions at 6q24.2-26 and ovarian cancer survival rates. Deletions at this chromosomal region have been studied in various cancers, including ovarian cancer, to understand their impact on patient outcomes. Research has shown that deletions at 6q24.2-26 are often associated with poor prognosis in several types of cancer, including ovarian cancer. These deletions can lead to the loss of tumor suppressor genes, which are essential for preventing uncontrolled cell growth and tumor progression. Studies have investigated the relationship between deletions at 6q24.2-26 and ovarian cancer survival rates, with a focus on overall survival and disease-free survival. The results suggest that patients with deletions at this chromosomal region tend to have shorter overall survival and disease-free survival rates compared to those without these deletions. Therefore, based on the available evidence, deletion at 6q24.2-26 is associated with shorter survival for ovarian cancer patients.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 39.98046255111694
}